## Note
nid: 1547242130939
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::2obgyn, #AK_Step2_v11::!Shelf::ObGyn::no_dupes, #AK_Step2_v11::!Shelf::ObGyn::no_dupes::only_step2, #AK_Step2_v11::#B&B::06_ObGyn::Obstetrics::03_AneuploidyScreening, #AK_Step2_v11::#OME::13_Obstetrics::02_Normal_Prenatal_Care, #AK_Step2_v11::#OME::13_Obstetrics::03_Genetic_Screening, #AK_Step2_v11::#OME_banner::Clinical::14_Obstetrics::02_Normal_Prenatal_Care, #AK_Step2_v11::#Resources_by_rotation::ObGyn::ome::ob::prenatal_care, #AK_Step2_v11::#Subjects::Obstetrics_&_Gynecology::02_Obstetrics_REDO::01_Pregnancy::Mother::Prenatal_Testing::Amniocentesis, #AK_Step2_v11::#Subjects::Obstetrics_&_Gynecology::02_Obstetrics_REDO::01_Pregnancy::Mother::Prenatal_Testing::Chorionic_Villous_Sampling, #AK_Step2_v11::#Subjects::Obstetrics_&_Gynecology::02_Obstetrics_REDO::01_Pregnancy::Mother::Prenatal_Testing::First_Trimester_Combined_Test, #AK_Step2_v11::Original_decks::Dorian::obgyn::ome::ob::prenatal_care
markdown: false

### Text
What is the <i>next step in management</i> of a <font color=
"#FC0280">positive</font> <u>first-trimester</u> <b>combined
test</b> or <u>second-trimester</u> <b>quadruple screen</b>?
<div>
  {{c1::<font color="#FC0280">Chorionic villus sampling</font>
  (10-13 weeks) or <font color="#FC0280">amniocentesis</font>
  (15-20 weeks)}}
</div>

### Extra
<div>
  <i>- For <b>karyotype analysis of fetus</b>; villus sampling
  examines the <u>placenta</u> while amniocentesis examines the
  <u>amniotic fluid</u></i>
</div>
<div>
  <div>
    <i>- Prenatal screening for congenital abnormalities should be
    offered to all women.</i>
  </div>
  <div>
    <i>- The first-trimester screen can be performed at 9-13 weeks
    gestation and is a screening, not diagnostic, test. The
    quadruple marker screen is a screening test for aneuploidy
    performed at 15-22 weeks gestation. It has a sensitivity and
    specificity comparable to the first-trimester screen and, for
    that reason, is not indicated as a follow-up to an abnormal
    first-trimester screen.</i>
  </div>
  <div>
    <i>- Follow-up for these findings is a diagnostic test that
    allows for fetal karyotyping.</i>
  </div>
  <div>
    <i>- If the patient declines invasive testing, an anatomy
    ultrasound and <b>cell-free fetal DNA test</b> (which has a
    higher sensitivity and specificity than the first-trimester
    screen) can be used to further analyze the risk for fetal
    aneuploidy. However, these tests are also nondiagnostic and
    cannot provide a definitive genetic or chromosomal
    diagnosis.</i>
  </div>
</div>
<div>
  <i><img src="paste-437627102691329.jpg"></i><img src=
  "paste-439624262483969.jpg"><i><img src=
  "paste-438683664646145.jpg"></i>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/obstetrics/normal-prenatal-care/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_4.png"></a>
</div>

### Additional Resources


### One by one

